loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 24d10449 2936 4cd3 B7db A7683db721e4 Applno 21660 Form Powder Intravenous Dosage 100mg Vial - Drug Product Composition: OncoGel

    Menu

    OncoGel

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21660 / DOSAGE - POWDER;INTRAVENOUS - 100MG/VIAL

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PACLITAXEL(UNII: P88XT4IS4D)
    (PACLITAXEL - UNII:P88XT4IS4D)     		PACLITAXEL100mg in 20

    Inactive Ingredients

    Ingredient Name
    Abraxis BioScience, LLC
    HBT Labs, Inc.
    ALBUMIN HUMAN(ZIF514RVZR)
    HYDROCHLORIC ACID(QTT17582CB) 
    SODIUM HYDROXIDE(55X04QC32I) 
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.